Frontline Antibiotic Therapy for Early Stage Helicobacter Pylori Negative Gastric MALT Lymphoma Running title: Antibiotic for HP-negative gastric MALT lymphoma Paolo Strati 1# , Seung Tae Lee 1,2# , Purnima Teegavarupu 1 , Anusha Karri 1 , Saswatha Anireddy 1 , Fredrick B Hagemeister 1 , Jorge Romaguera 1 , Luis E Fayad 1 , Maria A Rodriguez 1 , Felipe Samaniego 1 , Nathan Fowler 1 , Jason Westin 1 , Michael Wang, 1 Hun Ju Lee, 1 Chelsea Pinnix 3 , Jillian R Gunther 3 , Bouthaina Dabaja 3 , Lei Feng 3 , R Eric Davis 1 , Sattva S Neelapu 1 . 1 Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX; 2 Current address: University of Maryland, Baltimore, MD; 3 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 3 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX # PS and STL are co-first authors Correspondence: Sattva S Neelapu, MD Department of Lymphoma and Myeloma, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center 1515 Holcombe Boulevard, Unit 429, Houston, TX 77030, USA. E-mail: sneelapu@mdanderson.org; Telephone: (713) 563-3429; Fax: (713) 794-1830 Text word count: 1380; Supplement: 1; Figures: 1; References: 6 Scientific Category: Lymphoid neoplasia Accepted Article This article is protected by copyright. All rights reserved. This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/ajh.25447